Related Experiment Video
Updated: Feb 5, 2026

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
Successful Treatment of PD Peritonitis Due to Brevundimonas vesicularis
Daniel Christiadi1, Richard F Singer1,2, Darren M Roberts3,2
1Renal Medicine, The Canberra Hospital, Garran, ACT, Australia.
Abstract:
Brevundimonas vesicularis is a rare cause of peritoneal dialysis-associated peritonitis (PD peritonitis). One documented case report described poor outcome despite treatment with appropriate antibiotics. Here, we report the successful treatment of PD peritonitis due to Brevundimonas vesicularis with 21 days of intraperitoneal (IP) antibiotics using the regimen described for Pseudomonas aeruginosa, notably IP gentamicin (10 days) followed by IP cefepime and oral ciprofloxacin (11 days). Despite the favorable outcome, measurement of antibiotic concentrations in the PD effluent suggests that the cefepime and possibly ciprofloxacin regimens do not achieve key antibiotic concentration targets that are reported to maximize bacterial kill. The role of routine therapeutic drug monitoring to maximize clinical outcomes from antibiotic therapy for PD peritonitis requires further consideration.
Insights
Brevundimonas vesicularis peritonitis in peritoneal dialysis patients can be successfully treated with a 21-day antibiotic regimen. However, drug levels in dialysis fluid suggest suboptimal antibiotic concentrations, warranting further study.
Area of Science:
- Nephrology
- Infectious Diseases
- Microbiology
Background:
- Peritoneal dialysis (PD)-associated peritonitis is a serious complication.
- Brevundimonas vesicularis is an uncommon pathogen causing PD peritonitis, with previous reports indicating poor outcomes.
Observation:
- This report details a successful treatment of PD peritonitis caused by Brevundimonas vesicularis.
- The patient received a 21-day intraperitoneal (IP) antibiotic course, adapting a regimen used for Pseudomonas aeruginosa.
Findings:
- The treatment involved IP gentamicin for 10 days, followed by IP cefepime and oral ciprofloxacin for 11 days.
- Despite a favorable clinical outcome, antibiotic concentrations in PD effluent were below targets for maximal bacterial kill for cefepime and possibly ciprofloxacin.
Implications:
- This case demonstrates a viable antibiotic strategy for rare PD peritonitis pathogens.
- Therapeutic drug monitoring may be crucial for optimizing antibiotic efficacy in PD peritonitis to improve patient outcomes.
Related Concept Videos
Ecological Succession
PD Controller: Design
Designing a continuous-data controller requires selecting and linking components like adders and integrators, which are fundamental in Proportional,...
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Time-Domain Interpretation of PD Control
Consider the example of control of motor torque. Initially, a positive...
Frequency-Domain Interpretation of PD Control
The proportional control gain, combined with the...
Peritoneal Dialysis I: Introduction and Procedure

